Astria Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATXS and other ETFs, options, and stocks.About ATXS
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway.
CEOJill C. Milne
CEOJill C. Milne
Employees78
Employees78
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2008
Founded2008
Employees78
Employees78
ATXS Key Statistics
Market cap725.55M
Market cap725.55M
Price-Earnings ratio-5.91
Price-Earnings ratio-5.91
Dividend yield—
Dividend yield—
Average volume1.13M
Average volume1.13M
High today$12.78
High today$12.78
Low today$12.65
Low today$12.65
Open price$12.75
Open price$12.75
Volume1.48M
Volume1.48M
52 Week high$13.29
52 Week high$13.29
52 Week low$3.56
52 Week low$3.56
Stock Snapshot
With a market cap of 725.55M, Astria Therapeutics(ATXS) trades at $12.71. The stock has a price-to-earnings ratio of -5.91.
On 2025-12-19, Astria Therapeutics(ATXS) stock traded between a low of $12.65 and a high of $12.78. Shares are currently priced at $12.71, which is +0.5% above the low and -0.5% below the high.
The Astria Therapeutics(ATXS)'s current trading volume is 1.48M, compared to an average daily volume of 1.13M.
During the past year, Astria Therapeutics(ATXS) stock moved between $3.56 at its lowest and $13.29 at its peak.
During the past year, Astria Therapeutics(ATXS) stock moved between $3.56 at its lowest and $13.29 at its peak.
Analyst ratings
88%
of 8 ratingsBuy
12.5%
Hold
87.5%
Sell
0%
People also own
Based on the portfolios of people who own ATXS. This list is generated using Robinhood data, and it’s not a recommendation.